CoChat
Sign Up
Cited by 90Inflammatory Bowel DiseaseGastrointestinal motility and disordersMicroscopic Colitis

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being

Open access
Jonefjäll, Börje, Öhman, Lena, Simrén, Magnus, Strid, Hans·2016·Inflammatory Bowel Diseases
DOI 10.1097/mib.0000000000000921
Open this paper in CoChat — free account

Abstract

BACKGROUND: Gastrointestinal symptoms (GI) compatible with irritable bowel syndrome (IBS) are common in patients with ulcerative colitis (UC) in remission. The causes of these symptoms remain to be clarified. Our aim was to investigate prevalence and factors associated with IBS-like symptoms in patients with UC in deep remission. METHODS: We included 298 patients with UC and used Mayo score, sigmoidoscopy, and fecal calprotectin to define deep remission versus active disease. Presence of IBS-like symptoms according to the Rome III criteria, severity of GI, extraintestinal and psychological symptoms, stress levels, and quality of life were measured with validated questionnaires. Serum cytokines and high-sensitive C-reactive peptide were determined. RESULTS: The criteria for deep remission was fulfilled by 132 patients (44%) and 24 of these fulfilled the Rome III criteria for IBS (18%). Patients with UC in deep remission with IBS-like symptoms had comparable levels of GI symptoms, non-GI somatic symptoms, and quality of life as patients with active UC. The patients with UC in deep remission with IBS-like symptoms had similar levels of fecal calprotectin as patients in deep remission without IBS-like symptoms (18 versus 31 μg/g, P = 0.11), but higher levels of serum cytokines (interleukin [IL]-1β, IL-6, IL-13, IL-10 and IL-8, P < 0.05) and higher levels of anxiety (P < 0.001), depression (P = 0.02) and perceived stress (P = 0.03). CONCLUSIONS: IBS-like symptoms in patients with UC in deep remission are common, but not as prevalent as previously reported. Poor psychological well-being and increased serum cytokine levels, but not colonic low-grade inflammation, were associated with IBS-like symptoms.

Overview

Integrity signals

Registry

Crossref · 10.1097/mib.0000000000000921

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Simren, 2002, Am J Gastroenterol, 97, 389, 10.1111/j.1572-0241.2002.05475.x · DOI · Paper page

Cited by

Sorted by citations

See all 90

Related

See all

Metadata

Authors
Jonefjäll, B., Öhman, L., Simrén, M., & Strid, H.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • University of Skövde (SE)
  • Södra Älvsborg Hospital (SE)
Corresponding author
Jonefjäll, Börje
ORCID
Venue
Inflammatory Bowel Diseases
Publisher
Oxford University Press (OUP)
Published
2016-11
Volume
22
Issue
11
Pages
2630-2640
ISSN
1078-0998 (ISSN-L)
DOI
10.1097/mib.0000000000000921
OpenAlex
W2519572380
Cited by
90
References
41
Citations by year
2026: 6 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 11 · 2019: 12 · 2018: 12 · 2017: 12 · 2016: 3
FWCI
10.50
Type
journal article
Language
en
Open access
Locations
  • Inflammatory Bowel Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • AstraZeneca
  • Danone
  • Södra Älvsborgs Sjukhus
  • Göteborgs Läkaresällskap
  • Sahlgrenska Universitetssjukhuset
  • Göteborgs Universitet
  • Svenska Läkaresällskapet (SLS-329111)
  • Allergan
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords
ulcerative colitis, deep remission
MeSH terms
Symptom Flare Up, Adolescent, Adult, Aged, Anxiety, Colitis, Ulcerative, Depression, Female, Humans, Male, Middle Aged, Remission Induction, Severity of Illness Index, Stress, Psychological, Cytokines, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review